These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33221459)

  • 1. Novel immunoassay for diagnosis of ongoing Clostridioides difficile infections using serum and medium enriched for newly synthesized antibodies (MENSA).
    Haddad NS; Nozick S; Kim G; Ohanian S; Kraft C; Rebolledo PA; Wang Y; Wu H; Bressler A; Le SNT; Kuruvilla M; Cannon LE; Lee FE; Daiss JL
    J Immunol Methods; 2021 May; 492():112932. PubMed ID: 33221459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile Infection.
    Haddad NS; Nozick S; Kim G; Ohanian S; Kraft CS; Rebolledo PA; Wang Y; Wu H; Bressler A; Le SNT; Kuruvilla M; Runnstrom MC; Ramonell RP; Cannon LE; Lee FE; Daiss JL
    J Clin Microbiol; 2022 Mar; 60(3):e0220121. PubMed ID: 35107301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
    Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
    PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease.
    Haddad NS; Nozick S; Ohanian S; Smith R; Elias S; Auwaerter PG; Lee FE; Daiss JL
    PLoS One; 2023; 18(11):e0293203. PubMed ID: 37922270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 8. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking Anti-
    Oh I; Muthukrishnan G; Ninomiya MJ; Brodell JD; Smith BL; Lee CC; Gill SR; Beck CA; Schwarz EM; Daiss JL
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship.
    Schwenk HT; Pollock NR; Vaughan-Malloy AM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S16-S21. PubMed ID: 34791395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection in fever patients with gynecological malignancies.
    Yanazume S; Tokudome A; Fukuda M; Togami S; Kamio M; Ota S; Kobayashi H
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1200. PubMed ID: 32721136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective definition of low humoral response to Clostridioides difficile infection.
    Ramos-Martínez A; Serrano-Martínez F; Pintos I; Valencia-Alijo Á; Gutiérrez-Rojas Á; Cítores MJ; Ortiz-Balbuena J; Royuela A; Martínez-Ruiz R; Sánchez-Romero I; Asensio Á; Múñez E; Plaza A
    Anaerobe; 2021 Dec; 72():102475. PubMed ID: 34752901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study.
    Al-Thani AA; Hamdi WS; Al-Ansari NA; Doiphode SH; Wilson GJ
    BMC Infect Dis; 2014 Sep; 14():502. PubMed ID: 25223337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Laboratory Diagnosis of Clostridioides difficile Infection: An update of current laboratory practice.
    Somily AM; Khan MA; Morshed M
    J Infect Dev Ctries; 2021 Oct; 15(10):1364-1375. PubMed ID: 34780357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.